Original language | English |
---|---|
Pages (from-to) | 91-93 |
Number of pages | 3 |
Journal | Immunotherapy |
Volume | 13 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1 Feb 2021 |
Keywords
- cancer
- checkpoint inhibitors
- immunotherapy
- pembrolizumab
- rare
- sarcoma
Tarek Assi, Axel Le Cesne, Olivier Mir
Research output: Contribution to journal › Review article › peer-review
Original language | English |
---|---|
Pages (from-to) | 91-93 |
Number of pages | 3 |
Journal | Immunotherapy |
Volume | 13 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1 Feb 2021 |